Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements

被引:96
作者
Forde, A
Constien, R
Gröne, HJ
Hämmerling, G
Arnold, B
机构
[1] German Canc Res Ctr, Div Tumor Immunol, Dept Mol Immunol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany
关键词
inducible; tamoxifen; transgenic mice; conditional gene targeting; loxP;
D O I
10.1002/gene.10117
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The versatility of the bacteriophage Cre/LoxP system is dependent on the availability of a spectrum of tissue-specific Cre transgenic mice to address a host of biological questions. In this paper, we report on the generation of an inducible Tie2Cre transgenic mouse line that facilitates gene targeting exclusively in endothelial cells. The temporal manner of recombination is feasible through the use of a Cre-estrogen receptor fusion protein ERT2 and was, in practical terms, achieved by feeding the animals the estrogen antagonist tamoxifen orally for 5 weeks. High efficiency of recombination was found in the vast majority of endothelial cell populations examined, as monitored by an EGFP reporter mouse line. Critically, no EGFP expression was observed in any uninduced mice. This inducible Cre line will be a very beneficial asset to investigating the role of endothelial specific genes in the adult mouse and to induce transgenes in the endothelium in an extremely efficient manner. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 22 条
  • [1] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [2] Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line
    Constien, R
    Forde, A
    Liliensiek, B
    Gröne, HJ
    Nawroth, P
    Hämmerling, G
    Arnold, B
    [J]. GENESIS, 2001, 30 (01) : 36 - 44
  • [3] Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains
    Feil, R
    Wagner, J
    Metzger, D
    Chambon, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 752 - 757
  • [4] FURR BJ, 1979, PHARM BIOCH PROPERTI, P355
  • [5] THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN
    FURR, BJA
    JORDAN, VC
    [J]. PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) : 127 - 205
  • [6] INDEPENDENT CONTROL OF IMMUNOGLOBULIN SWITCH RECOMBINATION AT INDIVIDUAL SWITCH REGIONS EVIDENCED THROUGH CRE-IOXP-MEDIATED GENE TARGETING
    GU, H
    ZOU, YR
    RAJEWSKY, K
    [J]. CELL, 1993, 73 (06) : 1155 - 1164
  • [7] Trafficking of nuclear receptors in living cells
    Hager, GL
    Lim, CS
    Elbi, C
    Baumann, CT
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 74 (05) : 249 - 254
  • [8] Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor α mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes
    Imai, T
    Jiang, M
    Chambon, P
    Metzger, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 224 - 228
  • [9] Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis:: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinases
    Indra, AK
    Warot, X
    Brocard, J
    Bornert, JM
    Xiao, JH
    Chambon, P
    Metzger, D
    [J]. NUCLEIC ACIDS RESEARCH, 1999, 27 (22) : 4324 - 4327
  • [10] JANEWAY CA, 1984, J IMMUNOL, V132, P662